GHRP-6 vs MK-677
Research Verdict
MK-677 is the stronger research reference for the stated comparison criteria. MK-677: oral, Merck Phase 3 datasets in elderly (Nass 2008), 24-hour half-life.
Quick Answers
Which is better, GHRP-6 or MK-677?
MK-677 is the stronger research reference for the stated comparison criteria. MK-677: oral, Merck Phase 3 datasets in elderly (Nass 2008), 24-hour half-life.
What is the key difference between GHRP-6 and MK-677?
MK-677 produces continuous non-pulsatile GH elevation via oral dosing; GHRP-6 produces acute GH pulses via injection with pronounced appetite stimulation - oral convenience vs. pulsatile physiology and orexigenic effects.
Evidence Comparison
MK-677: oral, Merck Phase 3 datasets in elderly (Nass 2008), 24-hour half-life. GHRP-6: injectable, smaller studies, but well-characterized acute GH pulsatility and appetite stimulation. MK-677 has more formal clinical data; GHRP-6 has more detailed receptor pharmacology.
Evidence Context Favoring GHRP-6
Research where pulsatile GH release and appetite stimulation are relevant endpoints.
Evidence Context Favoring MK-677
Chronic oral dosing studies, patient convenience contexts, or research requiring larger published human datasets.
Side-by-Side Snapshot
| Evidence grade | GHRP-6: Level C MK-677: Level B |
|---|---|
| Research status | GHRP-6: Preclinical MK-677: Phase 3 |
| Primary category | GHRP-6: Growth Hormone MK-677: Growth Hormone |
| Cited studies | GHRP-6: 2 MK-677: 4 |